Dae Hwa Pharm Co Ltd
KOSDAQ:067080
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dae Hwa Pharm Co Ltd
KOSDAQ:067080
|
KR |
|
H
|
Henry Schein Inc
SWB:HS2
|
US |
|
O
|
Omni Bridgeway Ltd
F:MXG1
|
AU |
|
K
|
Keyrus SA
F:5UP
|
FR |
|
Pan Global Resources Inc
XTSX:PGZ
|
CA |
|
M
|
MNtech Co Ltd
KOSDAQ:095500
|
KR |
Intrinsic Value
Is Dae Hwa Pharm Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Dae Hwa Pharm Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Dae Hwa Pharm Co Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Dae Hwa Pharm Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Dae Hwa Pharm Does
Dae Hwa Pharm is a South Korean pharmaceutical company that makes and sells medicines, with a strong focus on external-use products such as patches, plasters, ointments, and other topical treatments. Its lineup also includes prescription drugs and over-the-counter medicines used for pain relief, inflammation, skin care, and other common medical needs. The company earns money by selling these products under its own brands and through pharmaceutical distribution channels.
- Headquarters
- Korea KR
- IPO date
- Feb 14, 2003
Revenue & Expenses Breakdown
Dae Hwa Pharm Co Ltd
Earnings Waterfall
Dae Hwa Pharm Co Ltd
The intrinsic value for Dae Hwa Pharm Co Ltd (067080) under the Base Case is hidden KRW.
Compared with the current market price of 9 930 KRW, the stock appears hidden.